Matt Niloff heads up Pall Biotech’s Integrated Solutions Program in the
Americas. He began his career at MIT working on The Human Genome
Project and went on to leading roles in the commercialization of singleuse
technologies at Millipore, Stedim, Xcellerex GE, and Pall. Matt holds a
Master of Science degree in biology from McGill University in Montreal.